SEARCH

SEARCH BY CITATION

References

  • 1
    The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 390918.
  • 2
    Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphoma. N Engl J Med 1984; 311: 14715.
  • 3
    Gallagher CJ, Gregory WM, Jones AE et al. Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol 1986; 4: 147080.
  • 4
    Harris NL, Ferry JA. Follicular lymphoma. In: Knowles DM, ed. Neoplastic Hematopathology, 2nd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2001; 82353.
  • 5
    Alsabeh R, Medeiros LJ, Glackin C et al. Transformation of follicular lymphoma into CD30-large cell lymphoma with anaplastic cytologic features. Am J Surg Pathol 1997; 21: 52836.
  • 6
    Yano T, Jaffe ES, Longo DJ et al. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80: 75867.
  • 7
    de Jong D, Voetdujk B, Bavestock G et al. Activation of the c-myc oncogene in a precursor B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med 1998; 318: 13738.
  • 8
    Brauninger A, Hansmann ML, Strickler JG et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med 1999; 340: 123947.
  • 9
    Marafioti T, Hummel M, Anagnostopoulos I et al. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol 1999; 17: 38049.
  • 10
    Ghesquières H, Berger F, Felman P et al. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis. J Clin Oncol 2006; 24: 523441.
  • 11
    Lossos IS, Alizadeh AA, Diehn M et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci USA 2002; 99: 888691.
  • 12
    Sander CA, Yano T, Clark HM et al. p53 mutation is associated with progression in follicular lymphomas. Blood 1993; 82: 19942004.
  • 13
    Davies AJ, Rosenwald A, Wright G et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol 2007; 136: 28693.
  • 14
    Pinyol M, Cobo F, Bea S et al. p16 (INF4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998; 91: 297784.
  • 15
    Elenitoba-Johnson KS, Gascoyne RD, Lim MS et al. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 1998; 91: 467785.
  • 16
    Hans CP, Weisenburger DD, Vose JM et al. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood 2003; 101: 23637.
  • 17
    Maeshima AM, Omatsu M, Nomoto J et al. Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses. Cancer Sci 2008; 99: 17608.
  • 18
    Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 50311.
  • 19
    Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med 2002; 346: 193747.
  • 20
    Hans SP, Weisenburger DD, Greiner TC et al. Conformation of molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 27582.
  • 21
    Godon A, Moreau A, Talmant P et al. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients Leukemia 2003; 17: 2559.
  • 22
    Biagi JJ, Suymour JF. Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood 2002; 99: 426575.
  • 23
    Sekiguchi N, Kobayashi Y, Yokota Y et al. Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis. Cancer Sci 2005; 96: 7782.
  • 24
    Swerdlow SH, Campo E, Harris NL et al. World health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.
  • 25
    Miller TP, Grogan TM, Dahlberg S et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood 1994; 83: 14606.
  • 26
    Maeshima AM, Taniguchi H, Fukuhara S et al. Bcl-2, Bcl-6, and IPI are prognostic indicators in patients with DLBCL treated with rituximab-containing chemotherapy. Cancer Sci 2012; 103: 1898904.
  • 27
    Nunez G, London L, Hockenbery D et al. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990; 144: 360210.
  • 28
    Gascoyne RD, Adomat SA, Krajewski S et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 1997; 90: 24451.
  • 29
    Hermine O, Haioun C, Lepage E et al. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groups d'Etude des Lymphomes de l'Adulte (GELA). Blood 1996; 87: 26572.
  • 30
    Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 50311.
  • 31
    Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med 2002; 346: 193747.
  • 32
    Colomo L, Lopez-Guillermo A, Perales M et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 2003; 101: 7884.